Please try another search
For the nine months ended 30 September 2021,Magellan Health Inc revenues increased 7% to $3.64B. Netincome before extraordinary items decreased 24% to $21.9M.Revenues reflect Pharmacy Management segment remaining flatat $1.95B. Net income was offset by Healthcare segmentincome decrease of 37% to $91.5M. Basic Earnings per Shareexcluding Extraordinary Items decreased from $1.16 to$0.85.
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Revenue | 1254.12 | 1220.77 | 1161.65 | 1184.96 |
Gross Profit | 37.98 | 32.3 | 66.12 | 7.17 |
Operating Income | 6.42 | -1.63 | 45.5 | -31.64 |
Net Income | 5.94 | -0.67 | 27.83 | 268.93 |
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Assets | 3353.45 | 3217.93 | 3236.51 | 3359.86 |
Total Liabilities | 1419.55 | 1294.11 | 1326.94 | 1489.88 |
Total Equity | 1933.9 | 1923.82 | 1909.57 | 1869.97 |
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 60.06 | -142.69 | -77.88 | 179.5 |
Cash From Investing Activities | -64.66 | -224.11 | -509.46 | 797.96 |
Cash From Financing Activities | -101.39 | -99.14 | -100.8 | 51.24 |
Net Change in Cash | -105.99 | -465.94 | -688.14 | 1028.7 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review